Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity

Publication | Open Access

DOI Full Paper Access

Citations

References

2004

Year

Mariana Salatino, Roxana Schillaci, Cecilia J. Proietti, Romina P. Carnevale, Isabel Frahm, Alfredo Molinolo, Adolfo M. Iribarren, Eduardo H. Charreau, Patricia V. Elizalde

Oncogene

Breast OncologyHormonal ReceptorAntisense OligodeoxynucleotidesCancer GrowthBreast CancerProgesterone Receptor ActivityRadiation OncologyMedicineCell BiologyCell SignalingTumor MicroenvironmentCancer ResearchEndocrine-related Cancer